Unaudited Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022	[1]
CURRENT ASSETS
Cash and cash equivalents	$ 237,665,601	$ 214,754,638
Restricted Cash	0	4,000,000
Short-term investments	20,172,297	23,007,385
Accounts receivable, net	350,409,472	276,493,752
Inventories	390,026,268	404,360,270
Prepaid expenses and other	27,032,788	26,036,331
Total current assets	1,025,306,426	948,652,376
PLANT AND EQUIPMENT—NET	596,694,337	550,033,036
OTHER ASSETS
Goodwill	313,647,268	313,807,494
Long-term investments	239,621,466	202,331,983
Intangible assets, net	209,710,910	219,360,910
Deferred tax asset	28,943,561	25,528,700
Patents and other assets, net	73,183,124	67,515,425
Total other assets	865,106,329	828,544,512
Total assets	2,487,107,092	2,327,229,924
CURRENT LIABILITIES
Accounts payable	168,456,476	151,740,046
Accrued liabilities	107,605,540	98,812,706
Total current liabilities	276,062,016	250,552,752
OTHER NON-CURRENT LIABILITIES	15,095,750	10,884,351
Total liabilities	291,157,766	261,437,103
SHAREHOLDERS’ INVESTMENT
Common stock	14,005,799	14,050,160
Additional paid-in capital	942,660,764	917,499,323
Retained earnings	1,252,525,531	1,148,386,272
Accumulated other comprehensive loss	(13,242,768)	(14,142,934)
Total shareholders’ investment	2,195,949,326	2,065,792,821
Total liabilities and shareholders’ investment	$ 2,487,107,092	$ 2,327,229,924

[1] The condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.